The Cytel blog keeps you up to speed with the latest developments in biostatistics and clinical biometrics.
Subgroup Analyses in Early Phase Clinical Trials
May 10, 2016
We were fortunate to welcome Björn Bornkamp of Novartis to the EUGM 2016 presenting work he has developed jointly with Marius Thomas (1) on methods of adjusting treatment effect estimates in subgroup analyses with a focus on early phase trials.